Concept information
Preferred term
CA-19-9 Antigen
Type
-
mesh:Descriptor
Definition
- Sialylated Lewis(a) blood group carbohydrate antigen found in many adenocarcinomas of the digestive tract, especially pancreatic tumors.
Broader concept
Entry terms
- 5-Acetylneuraminyl-2-3-Galactosyl-1-3-(Fucopyranosyl-1-4)-N-Acetylglucosamine
- alpha-Neu5Ac-(2-3)-beta-D-Gal-(1-3)-(alpha-L-Fuc-(1-4))-beta-D-GlcNAc
- Antigen CA-19-9
- CA 19-9 Antigen
- CA 19.9 Antigen
- Gastrointestinal Cancer Antigen
- NAG-1,3-F-1,4-GN
- Neu5Ac-2-3-Gal-1-3-(Fuc-1-4)-GlcNAc
- Sialyl Le(a)
- Sialyl Lewis A
- Sialyl Lewis A Antigen
- Sialyl Lewis(a) Tetrasaccharide
Allowable Qualifier(s)
- administration & dosage (Qualifier)
- adverse effects (Qualifier)
- analysis (Qualifier)
- biosynthesis (Qualifier)
- blood (Qualifier)
- cerebrospinal fluid (Qualifier)
- chemistry (Qualifier)
- classification (Qualifier)
- drug effects (Qualifier)
- economics (Qualifier)
- genetics (Qualifier)
- history (Qualifier)
- immunology (Qualifier)
- isolation & purification (Qualifier)
- metabolism (Qualifier)
- pharmacology (Qualifier)
- physiology (Qualifier)
- poisoning (Qualifier)
- radiation effects (Qualifier)
- therapeutic use (Qualifier)
- toxicity (Qualifier)
- ultrastructure (Qualifier)
- urine (Qualifier)
In other languages
-
French
-
Antigène CA-19-9
-
Antigène du cancer gastro-intestinal
URI
http://data.loterre.fr/ark:/67375/JVR-RB8933S3-X
{{label}}
{{#each values }} {{! loop through ConceptPropertyValue objects }}
{{#if prefLabel }}
{{/if}}
{{/each}}
{{#if notation }}{{ notation }} {{/if}}{{ prefLabel }}
{{#ifDifferentLabelLang lang }} ({{ lang }}){{/ifDifferentLabelLang}}
{{#if vocabName }}
{{ vocabName }}
{{/if}}